Raju Mantena, president and CEO of Orlando-based Icore, an injectable drug management company, has a strict warning for health plans: "Plans need to prepare themselves to slow the increase in injectable spending rather than trying to stop it, because it's not going to stop," he says.
Get the latest industry news, event updates, and more from Managed healthcare Executive.